Given the lack of biomarkers to guide psychiatric diagnoses, machine learning has been increasingly applied to develop brain-based hallmarks. Thus, neuroimaging-based artificial intelligence (AI) models have proliferated rapidly during the past 3 decades. Rather than enabling a clinician-based diagnosis of discrete symptoms, neuroimaging-based AI models enable an objective, symptom-centered, individualized and neurobiologically explicable estimate of psychiatric conditions.
1,2 In this vein, these models show considerable potential to be translated for use in early diagnosis, treatment development, and clinical decision-making.
3-7 However, lack of an evidence-based systematic appraisal of AI models impedes stakeholder enthusiasm for applying them in clinical practice.
8,9